Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer

BACKGROUND: Despite benefits of endocrine therapy (ET) for patients with hormone-receptor (HR)-positive breast cancer, many patients do not initiate or discontinue ET against recommendations. METHODS: We identified variables associated with ET initiation and continuation, analyzing pooled data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Beomyoung, Pérez, Maria, Jeffe, Donna B., Kreuter, Matthew W., Margenthaler, Julie A., Colditz, Graham A., Liu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341086/
https://www.ncbi.nlm.nih.gov/pubmed/35915419
http://dx.doi.org/10.1186/s12885-022-09946-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341086/
https://www.ncbi.nlm.nih.gov/pubmed/35915419
http://dx.doi.org/10.1186/s12885-022-09946-x

Ejemplares similares